These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3621221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Slayton RE, Blessing JA, Homesley HD.
    Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapy of squamous cell carcinoma of the cervix, vagina, and vulva.
    Malkasian GD, Decker DG, Mussey E, Johnson CE.
    Clin Obstet Gynecol; 1968 Jun; 11(2):367-81. PubMed ID: 4879371
    [No Abstract] [Full Text] [Related]

  • 4. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Slayton RE, Blessing JA, Delgado G.
    Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
    [No Abstract] [Full Text] [Related]

  • 5. Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
    Slayton RE, Blessing JA, DiSaia PJ, Christopherson WA.
    Cancer Treat Rep; 1987 Jun; 71(6):661-2. PubMed ID: 3034423
    [No Abstract] [Full Text] [Related]

  • 6. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, Lacave AJ, van Hoesel Q, Cervantes A, Bolis G, Namer M, Lhommé C, Guastalla JP, Nooij MA, Poveda A, Scotto di Palumbo V, Vermorken JB.
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [Abstract] [Full Text] [Related]

  • 7. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG, Blessing JA, Van Le L, Waggoner S.
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [Abstract] [Full Text] [Related]

  • 8. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva.
    Tropé C, Johnsson JE, Larsson G, Simonsen E.
    Cancer Treat Rep; 1980 Aug; 64(4-5):639-42. PubMed ID: 6159078
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
    Slayton RE, Creasman WT, Petty W, Bundy B, Blessing JA.
    Cancer Treat Rep; 1979 Aug; 63(11-12):2089-92. PubMed ID: 526942
    [No Abstract] [Full Text] [Related]

  • 10. Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
    Slavik M, Arsenau JC, Blessing J, Lewis GC.
    Am J Clin Oncol; 1982 Oct; 5(5):483-6. PubMed ID: 6897490
    [No Abstract] [Full Text] [Related]

  • 11. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Slayton RE, Blessing JA, Stehman FB, Malfetano J.
    Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494
    [No Abstract] [Full Text] [Related]

  • 12. [Chemotherapy of carcinoma of the vulva and vagina. Current approaches].
    Sesti F, Ciancio F, Bancheri C, Iannarilli P, Silvestri C, Piccione E.
    G Ital Oncol; 1989 Sep; 9(4):117-20. PubMed ID: 2693347
    [Abstract] [Full Text] [Related]

  • 13. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study.
    Muss HB, Bundy BN, Christopherson WA.
    Am J Clin Oncol; 1989 Apr; 12(2):142-4. PubMed ID: 2705404
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA, Shingleton HM, Creasman WT, Blessing JA, Boronow RC.
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract] [Full Text] [Related]

  • 15. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS, Blessing JA, Boike G.
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [Abstract] [Full Text] [Related]

  • 16. Adriamycin treatment of advanced vulvar carcinoma.
    Deppe G, Bruckner HW, Cohen CJ.
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):13s-14s. PubMed ID: 876532
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Bonomi P, Blessing JA, Sedlacek TV, Homesley HD, DiSaia PJ.
    Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
    [No Abstract] [Full Text] [Related]

  • 18. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG, Blessing JA, Arseneau J.
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [Abstract] [Full Text] [Related]

  • 19. Healing of vulvo-vaginal radionecrosis following revascularization.
    Hoffman KE, Horowitz NS, Russell AH.
    Gynecol Oncol; 2007 Jul; 106(1):262-4. PubMed ID: 17507081
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
    Witherspoon RP, Legha SS, Reimer RR, Talley RW, Stuckey WJ, Dixon DO, McCracken JD, Stephens RL, Oishi N.
    Cancer Treat Rep; 1984 Feb; 68(2):435-6. PubMed ID: 6546532
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.